open access

Vol 3, No 4 (2007)
Review paper
Published online: 2007-07-27
Get Citation

Recombinant human erythropoietin in treatment of the cancer patients with anemia: hopes and threats

Piotr Winczura, Jacek Jassem
Onkol. Prak. Klin 2007;3(4):198-204.

open access

Vol 3, No 4 (2007)
REVIEW ARTICLES
Published online: 2007-07-27

Abstract

The article is a summary of the current knowledge on the role of human recombinant erythropoietin in treatment of cancer patients with anemia. The molecular mechanism of erythropoietin action in cancer cells, as well as the latest recommendations of the scientifc societies on the use of recombinant human erythropoietin in cancer patients are presented. We also discuss results of the clinical trials demonstrating the potential negative impact of recombinant human erythropoietin on survival in cancer patients.

Abstract

The article is a summary of the current knowledge on the role of human recombinant erythropoietin in treatment of cancer patients with anemia. The molecular mechanism of erythropoietin action in cancer cells, as well as the latest recommendations of the scientifc societies on the use of recombinant human erythropoietin in cancer patients are presented. We also discuss results of the clinical trials demonstrating the potential negative impact of recombinant human erythropoietin on survival in cancer patients.
Get Citation

Keywords

erythropoietin; recombinant human erythropoietin; erythropoietin receptor; cancer

About this article
Title

Recombinant human erythropoietin in treatment of the cancer patients with anemia: hopes and threats

Journal

Oncology in Clinical Practice

Issue

Vol 3, No 4 (2007)

Article type

Review paper

Pages

198-204

Published online

2007-07-27

Bibliographic record

Onkol. Prak. Klin 2007;3(4):198-204.

Keywords

erythropoietin
recombinant human erythropoietin
erythropoietin receptor
cancer

Authors

Piotr Winczura
Jacek Jassem

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl